Fecal microbiota transplantation as a salvage therapy for concomitant resistant digestive graft versus host disease and cryptosporidiosis in a patient post hematopoietic stem cell transplant : about a case

Main Article Content

Thomas Finotto
a:1:{s:5:"en_US";s:20:"CHU Clermont-ferrand";}

Carole Chevenet
CHU Clermont-ferrand

Amandine Fayard
CHU Clermont-ferrand

Keywords

Allogeneic haemopietic stem stell transplantation , re-admission, length of stay, healthcare and personalized medical care, Graft versus host disease, cryptosporidiosis

Abstract

Chronic myeloid leukemia (CML) is a hematologic malignancy characterized by an uncontrolled proliferation of myeloid cells, particularly neutrophils. It is revealed through the detection of a Philadelphia chromosome (BCR;ABL).


While tyrosine kinase inhibitors have dramatically improved short and middle-term outcomes, in some resistant or relapsing cases, allogeneic hematopoietic stem cell transplantation (HSCT) can be a curative option.


In this first-ever documented case, we report the successful use of fecal microbiota transplantation (FMT) to treat both corticosteroid-resistant gastrointestinal GvHD and concomitant cryptosporidiosis, leading to significant clinical improvement in a patient post umbilical cord blood HSCT.

Downloads

Download data is not yet available.


Abstract 370
PDF Downloads 284
HTML Downloads 34

References

1. Legrand F, Grenouillet F, Larosa F et al. Diagnosis and treatment of digestive cryptosporidiosis in allogeneic haematopoietic stem cell transplant recipients: a prospective single centre study Bone Marrow Transplant. 2011, 46(6):858-62


2. La Hoz R et al. Intestinal parasites including Cryptosporidium, Cyclospora, Giardia, and Microsporidia, Entamoeba histolytica, Strongyloides, Schistosomiasis, and Echinococcus: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice Clinical transplant. 2019, 33(9):e13618

3. Staffas A et al. The intestinal microbiota in allogeneic hematopoietic cell transplant and graft-versus-host disease Blood 2017, 129(8):927-933


4. Kaito S, Toya T et al. Fecal microbiota transplantation with frozen capsules for a patient with refractory acute gut graft-versus-host disease. Blood Adv. 2018, 2(22):3097-3101

5. Kakihana K, Fujioka Y et al. Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut. Blood 2016, 128(16):2083-2088

Article Sidebar

PDF HTML
Published
Apr 30, 2025
DOI https://doi.org/10.4084/MJHID.2025.035

Article Details

How to Cite

Finotto, T., Chevenet, C. and Fayard, A. (2025) “Fecal microbiota transplantation as a salvage therapy for concomitant resistant digestive graft versus host disease and cryptosporidiosis in a patient post hematopoietic stem cell transplant : about a case”, Mediterranean Journal of Hematology and Infectious Diseases, 17(1), p. e2025035. doi: 10.4084/MJHID.2025.035.
Issue
Vol. 17 No. 1 (2025): Review Articles, Original Article, Scientific Letter, Case Reports Letter to the Editor
Section
Letters to the Editor
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Transfer of Copyright and Permission to Reproduce Parts of Published Papers. Authors will grant copyright of their articles to the Institute of Hematology, Catholic University, Rome . No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.